Education
About Us
Working with TipRanks
Follow Us
Torii Pharmaceutical Co (TRXPF)
:TRXPF
TRXPF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$19.82 - $39.03
Previous CloseN/A
Volume20.00
Average Volume (3M)0.00
Market Cap
$1.21B
Enterprise Value$174.45B
Total Cash (Recent Filing)$43.30B
Total Debt (Recent Filing)¥429.00M
Price to Earnings (P/E)28.2
Beta0.40
Next Earnings
Jul 31, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 27, 2025Dividend Yield5.12%
Share Statistics
EPS (TTM)0.34
Shares Outstanding28,800,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio3.15
Price to Book (P/B)1.47
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Torii Pharmaceutical Co News
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.73% Mutual Funds
― Other Institutional Investors
96.79% Public Companies and
Individual Investors
TRXPF FAQ
What was Torii Pharmaceutical Co ’s price range in the past 12 months?
Torii Pharmaceutical Co lowest stock price was $19.82 and its highest was $39.03 in the past 12 months.
What is Torii Pharmaceutical Co ’s market cap?
Torii Pharmaceutical Co ’s market cap is $1.21B.
When is Torii Pharmaceutical Co ’s upcoming earnings report date?
Torii Pharmaceutical Co ’s upcoming earnings report date is Jul 31, 2025 which is in 8 days.
How were Torii Pharmaceutical Co ’s earnings last quarter?
Torii Pharmaceutical Co released its earnings results on Apr 25, 2025. The company reported $0.335 earnings per share for the quarter, beating the consensus estimate of N/A by $0.335.
Is Torii Pharmaceutical Co overvalued?
According to Wall Street analysts Torii Pharmaceutical Co ’s price is currently Overvalued.
Does Torii Pharmaceutical Co pay dividends?
Torii Pharmaceutical Co pays a Semiannually dividend of $0.407 which represents an annual dividend yield of 5.12%. See more information on Torii Pharmaceutical Co dividends here
What is Torii Pharmaceutical Co ’s EPS estimate?
Torii Pharmaceutical Co ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Torii Pharmaceutical Co have?
Torii Pharmaceutical Co has 28,800,000 shares outstanding.
What happened to Torii Pharmaceutical Co ’s price movement after its last earnings report?
Torii Pharmaceutical Co reported an EPS of $0.335 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.972%.
Which hedge fund is a major shareholder of Torii Pharmaceutical Co ?
Currently, no hedge funds are holding shares in TRXPF
Company Description
Torii Pharmaceutical Co
Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.
Technical Analysis
Kaken Pharmaceutical Co
―
Kissei Pharmaceutical Co
―
Towa Pharmaceutical Co
―
Mochida Pharmaceutical Co., Ltd.
―
SAWAI GROUP HOLDINGS Co., Ltd.
―